Culler MD - Search Results

1

Expression and function of somatostatin receptor subtype 1 in human growth hormone secreting pituitary tumors deriving from patients partially responsive or resistant to long-term treatment with somatostatin analogs.

Matrone C, Pivonello R, Colao A, Cappabianca P, Cavallo LM, Del Basso De Caro ML, Taylor JE, Culler MD, Lombardi G, Di Renzo GF, Annunziato L. Matrone C, et al. Among authors: culler md. Neuroendocrinology. 2004 Mar;79(3):142-8. doi: 10.1159/000077272. Epub 2004 Apr 16. Neuroendocrinology. 2004. PMID: 15103227 Clinical Trial.

2

Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors.

Shimon I, Yan X, Taylor JE, Weiss MH, Culler MD, Melmed S. Shimon I, et al. Among authors: culler md. J Clin Invest. 1997 Nov 1;100(9):2386-92. doi: 10.1172/JCI119779. J Clin Invest. 1997. PMID: 9410919 Free PMC article.

3

Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment.

Tulipano G, Soldi D, Bagnasco M, Culler MD, Taylor JE, Cocchi D, Giustina A. Tulipano G, et al. Among authors: culler md. Endocrinology. 2002 Apr;143(4):1218-24. doi: 10.1210/endo.143.4.8716. Endocrinology. 2002. PMID: 11897676

4

The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat.

Tulipano G, Rossi E, Culler MD, Taylor JE, Bonadonna S, Locatelli V, Cocchi D, Giustina A. Tulipano G, et al. Among authors: culler md. Regul Pept. 2005 Feb 15;125(1-3):85-92. doi: 10.1016/j.regpep.2004.07.027. Regul Pept. 2005. PMID: 15582718

5

Selective stimulation of somatostatin receptor subtypes: differential effects on Ras/MAP kinase pathway and cell proliferation in human neuroblastoma cells.

Cattaneo MG, Taylor JE, Culler MD, Nisoli E, Vicentini LM. Cattaneo MG, et al. Among authors: culler md. FEBS Lett. 2000 Sep 22;481(3):271-6. doi: 10.1016/s0014-5793(00)02012-3. FEBS Lett. 2000. PMID: 11007977 Free article.

6

Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line tt.

Zatelli MC, Tagliati F, Taylor JE, Rossi R, Culler MD, degli Uberti EC. Zatelli MC, et al. Among authors: culler md. J Clin Endocrinol Metab. 2001 May;86(5):2161-9. doi: 10.1210/jcem.86.5.7489. J Clin Endocrinol Metab. 2001. PMID: 11344221

7

Somatostatin receptor subtypes: targeting functional and therapeutic specificity.

Culler MD, Taylor JE, Moreau JP. Culler MD, et al. Ann Endocrinol (Paris). 2002 Apr;63(2 Pt 3):2S5-12. Ann Endocrinol (Paris). 2002. PMID: 12037501 Review.

8

Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT.

Zatelli MC, Tagliati F, Taylor JE, Piccin D, Culler MD, degli Uberti EC. Zatelli MC, et al. Among authors: culler md. Horm Metab Res. 2002 May;34(5):229-33. doi: 10.1055/s-2002-32134. Horm Metab Res. 2002. PMID: 12063634

9

In vitro antiangiogenic activity of selective somatostatin subtype-1 receptor agonists.

Bocci G, Culler MD, Fioravanti A, Orlandi P, Fasciani A, Colucci R, Taylor JE, Sadat D, Danesi R, Del Tacca M. Bocci G, et al. Among authors: culler md. Eur J Clin Invest. 2007 Sep;37(9):700-8. doi: 10.1111/j.1365-2362.2007.01848.x. Eur J Clin Invest. 2007. PMID: 17696959

10

Evidence for differential effects of selective somatostatin receptor subtype agonists on alpha-subunit and chromogranin a secretion and on cell viability in human nonfunctioning pituitary adenomas in vitro.

Zatelli MC, Piccin D, Bottoni A, Ambrosio MR, Margutti A, Padovani R, Scanarini M, Taylor JE, Culler MD, Cavazzini L, degli Uberti EC. Zatelli MC, et al. Among authors: culler md. J Clin Endocrinol Metab. 2004 Oct;89(10):5181-8. doi: 10.1210/jc.2003-031954. J Clin Endocrinol Metab. 2004. PMID: 15472224

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters